Mondaq USA: Food, Drugs, Healthcare, Life Sciences > Food and Drugs Law
McDermott Will & Emery
On April 30, 2018, the U.S. District Court for the District of Massachusetts dismissed the last remaining state FCA claims against long-term care pharmacy provider PharMerica, Inc. on the grounds that neither relator...
Cooley LLP
Earlier this month, Tennessee House Bill 2220 was enacted, which provides, "A pharmaceutical manufacturer or its representatives may engage in the truthful promotion of off-label uses."
Akin Gump Strauss Hauer & Feld LLP
As stakeholders review the aforementioned Medicare policies, there will be additional questions regarding implementation and potential savings to the system.
Foley & Lardner
In Sumitomo Dainippon Pharma Co. V. Emcure Pharm. Ltd., the Federal Circuit affirmed the district court's decision that construed a chemical structure as reading on the lurasidone enantiomer...
WilmerHale
We provide below an overview of the state of the law.
Frankfurt Kurnit Klein & Selz
Yesterday, in Cigar Association of America v. U.S. Food and Drug Administration, the United States District Court for the District of Columbia ...
Reed Smith
A case from Alabama this week got us to thinking about two topics on which we write a lot — innovator liability and personal jurisdiction.
Reed Smith
The Trump Administration has launched a high-profile initiative aimed at reducing prescription drug prices, including release of a blueprint containing a series of short- and long-term policy proposals...
Reed Smith
Congress is considering a wide range of legislative proposals that seek to address the continuing opioid crisis.
Singh & Associates
On April 09, 2018, Verastem, a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients...
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
This week, the House Energy & Commerce Committee will hold its second round markup of opioid-related legislation.
Holland & Knight
"American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs," released on May 11, 2018, outlines the much-anticipated set of actions...
Arnold & Porter
On May 11, the Trump Administration unveiled its much anticipated plan for reducing drug prices and patient out-of-pocket costs, with a "Blueprint" document ...
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Businesses engaged in human drug compounding, both traditional pharmacies and the more recently created outsourcing facilities, have been on quite a rollercoaster ride ...
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
On Friday, after weeks of delay, the President finally delivered his Drug Pricing Speech and released the HHS Blueprint detailing the Trump Administration's plan to lower drug prices and reduce out-of-pocket costs.
Arnold & Porter
This year has been marked by robust efforts by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) to modernize food labeling in the United States.
Thompson Coburn LLP
The USDA published long-awaited proposed rules for the National Bioengineered Food Disclosure Standard. Here's what food companies need to know.
Cooley LLP
Today, the President and Health and Human Services (HHS) Secretary Alex Azar unveiled a 44-page Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs, designed to bring "soaring drug prices back down to earth."
Van Bael & Bellis
Of immediate relevance for third countries is the APF's assault against "foreign governments' free-riding off American investment in innovation".
Seyfarth Shaw LLP
Welcome back to The Week in Weed, your Friday look at what's happening in the world of legalized marijuana.
Latest Video
Most Popular Recent Articles
Reed Smith
With plaintiffs desperate to find some way to continue pursuing aggravated, aggregated product liability litigation in their favorite venues after Daimler AG v. Bauman ...
Shearman & Sterling LLP
This past year has seen renewed challenges to reverse payment settlement agreements in the pharmaceutical industry.
Troutman Sanders LLP
On January 30, 2018, three separate challenges to the Deeming Regulations were filed by vapor-industry plaintiffs represented by the Pacific Legal Foundation ("PLF")...
BakerHostetler
More than two dozen House Republicans last week called on President Donald Trump to leverage upcoming trade negotiations to stop other nations from "free riding" on U.S. pharmaceutical innovations.
Morrison & Foerster LLP
You've created a great product and built a valued brand. You've devoted countless hours to building relationships with key distributors and retailers, designing attractive packaging ...
Sheppard Mullin Richter & Hampton
The legalization of recreational use of marijuana in several states, including California, has left many employment policies vague and confused.
Dentons
The following legislative speed read comes by way of Dentons50 partner Manis, Canning–editorThe 2018 General Assembly Session came to a close at midnight on April 9. A total of 3,127 ...
McDermott Will & Emery
Fortune's April 2018 cover story, "Tech's Next Big Wave: Big Data Meets Biology," conveys loudly and clearly that technological innovation is transforming the health care continuum ...
Seyfarth Shaw LLP
No. We are not there yet. Are we making progress? Maybe.
Arnold & Porter
This year has been marked by robust efforts by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) to modernize food labeling in the United States.
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with